Detailed information for compound 1974924

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 286.331 | Formula: C18H14N4
  • H donors: 0 H acceptors: 3 LogP: 3.35 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1cncn1c1ccc2c(c1)cnc(n2)c1ccccc1
  • InChi: 1S/C18H14N4/c1-13-10-19-12-22(13)16-7-8-17-15(9-16)11-20-18(21-17)14-5-3-2-4-6-14/h2-12H,1H3
  • InChiKey: VLGUSAUTDZUDEF-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens monoamine oxidase A Starlite/ChEMBL No references
Homo sapiens monoamine oxidase B Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH Get druggable targets OG5_130722 All targets in OG5_130722
Mycobacterium tuberculosis Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) Get druggable targets OG5_130722 All targets in OG5_130722
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH Get druggable targets OG5_130722 All targets in OG5_130722
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi amine oxidase, flavin-containing family protein monoamine oxidase B 520 aa 462 aa 19.7 %
Brugia malayi amine oxidase, flavin-containing family protein monoamine oxidase A 527 aa 474 aa 22.4 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Leishmania major aminopeptidase, putative,metallo-peptidase, Clan MA(E), Family M1 0.0095 0 0.5
Echinococcus granulosus aminopeptidase N 0.0323 0.3669 1
Loa Loa (eye worm) hypothetical protein 0.029 0.3131 1
Trichomonas vaginalis Clan MA, family M1, aminopeptidase N-like metallopeptidase 0.0095 0 0.5
Trypanosoma brucei metallo-peptidase, Clan MA(E) Family M1 0.0095 0 0.5
Schistosoma mansoni cytosol alanyl aminopeptidase (M01 family) 0.0095 0 0.5
Trypanosoma brucei Aminopeptidase M1, putative 0.0095 0 0.5
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH 0.0717 1 1
Onchocerca volvulus 0.0323 0.3669 1
Trypanosoma brucei Aminopeptidase M1, putative 0.0095 0 0.5
Trypanosoma cruzi metallo-peptidase, clan MA(E), family M1, putative 0.0095 0 0.5
Loa Loa (eye worm) peptidase family M1 containing protein 0.0262 0.2677 0.8549
Mycobacterium tuberculosis Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) 0.0667 0.9188 0.5
Trypanosoma cruzi aminopeptidase, putative 0.0095 0 0.5
Echinococcus multilocularis aminopeptidase N 0.0323 0.3669 1
Brugia malayi Peptidase family M1 containing protein 0.0323 0.3669 1
Leishmania major aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 0.0095 0 0.5
Trypanosoma cruzi Aminopeptidase M1, putative 0.0095 0 0.5
Trichomonas vaginalis Clan MA, family M1, aminopeptidase N-like metallopeptidase 0.0095 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0228 0.2139 0.683
Schistosoma mansoni aminopeptidase PILS (M01 family) 0.0095 0 0.5
Entamoeba histolytica aminopeptidase, putative 0.0095 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 10000 nM BindingDB_Patents: Activity Assay. Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase activity (MAOs) from recombinant source (microsomes from baculovirus infected insect cells, Sigma). Experiments were performed according to the Supplier's procedure, incubating human recombinant MAO-A or MAO-B with a luminogenic substrate, a derivative of beetle luciferin ((4S)-4,5-dihydro-2-(6-hydroxybenzothiazolyl)-4-thiazolecarboxylic acid). MAOs converts this luciferin derivative to methyl ester luciferin and only compounds that interfere with the ability of the enzyme to use the pro-luminescent substrate will cause changes in the resulting luminescent signal. ChEMBL. No reference
IC50 (binding) = 10000 nM Activity Assay BINDINGDB. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.